Anti-Tumor Effects anti-tumor A An Ant Anti BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 --- 3 10 0 1 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
Polymerase Activity polymerase P Po Pol Poly BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 3 0 1 0 0 1
Moe Kawamura moe M Mo Moe Moe BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,,*,, 6 10 0 0 0 0 1
Hiromi Yoshida hiromi H Hi Hir Hiro BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,* 3 4 0 0 0 0 1
1 Graduate 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 ,,,,,,, 7 10 0 0 0 0 1
Kobe Gakuin kobe K Ko Kob Kobe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,,,,,, 8 7 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
We previously we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 (,--,-) 7 8 0 0 0 0 1
mitochondrial DNA mitochondrial m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ().,(----,-), 13 9 0 0 0 0 1
and chemically and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ::(--). 7 9 0 0 0 0 1
chemically modified chemically c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
with chains with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 10 0 0 0 0 1
c. Plumbagin c. c c. c. c. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 .(:-) 5 8 0 0 0 0 1
carcinoma (HCT116) carcinoma c ca car carc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()--., 6 9 0 0 0 0 1
DNA replicative dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,. 2 9 0 0 0 0 1
C18:1-Acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 :-, 3 9 0 0 0 0 1
other pols other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
lines, and lines, l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,-(.) 5 9 0 0 0 0 1
the nine the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .--,:- 6 9 0 0 0 0 1
acyl plumbagin acyl a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 .-- 3 9 0 0 0 0 1
anti-cancer agents anti-cancer a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -., 3 9 0 0 0 0 1
plumbagin is plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -, 2 9 0 0 0 0 1
plumbagin. plumbagin. plumbagin. p pl plu plum BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 0 0 0 0 0 1
Citation: Kawamura citation: C Ci Cit Cita BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :,,,,,.()--- 12 10 0 0 0 0 1
Mammalian DNA mammalian M Ma Mam Mamm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 .():.:./.. 10 6 0 0 0 0 1
Editor: Hitoshi editor: E Ed Edi Edit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :,, 3 10 0 0 0 0 1
Received November received R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,;,;, 5 10 0 0 0 0 1
Copyright: ÃŸ copyright: C Co Cop Copy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 :.-, 4 10 0 1 0 0 1
unrestricted use, unrestricted u un unr unre BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,,,. 4 7 0 1 0 0 1
Funding: This funding: F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 :(,,,,)- 8 9 0 1 0 0 1
Strategic Research strategic S St Str Stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ,-...--()(.), 13 10 0 1 0 0 1
Hyogo Science hyogo H Hy Hyo Hyog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ()...--()(.).... 16 9 0 1 0 0 1
acknowledge a acknowledge a ac ack ackn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ---(-)()( 9 9 0 1 0 0 1
Science and science S Sc Sci Scie BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ).,,,. 6 9 0 1 0 0 1
Competing Interests: competing C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :. 2 10 0 1 0 0 1
* E-mail: * * * * * BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 7 *-:@..();@...() 15 10 0 1 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 1 0 0 1
Cancer is cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 .- 2 8 0 1 0 0 1
ical and ical i ic ica ical BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 8 0 1 0 0 1
natural products natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 8 0 1 0 0 1
development [1,2]. development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 7 [,]., 5 8 0 1 0 0 1
polymerases (pols) polymerases p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ()-, 4 9 0 1 0 0 1
anti-viral, anti-parasitic, anti-viral, a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 -,-,- 5 9 0 1 0 0 1
are known are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 - 1 8 0 1 0 0 1
tion, and tion, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ,[,]. 5 4 0 1 0 0 1
Pol (DNA-dependent pol P Po Pol Pol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 (-,.....) 9 8 0 1 0 0 1
deoxyribonucleotide addition deoxyribonucleotide d de deo deox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 - 1 8 0 1 0 0 1
primed double-stranded primed p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 -()[]. 6 8 0 1 0 0 1
genome encodes genome g ge gen geno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 , 1 9 0 1 0 0 1
DNA synthesis dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 [,]. 4 9 0 1 0 0 1
(a, d, (a, ( (a (a, (a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (,,),(),- 9 8 0 1 0 0 1
replicative pols replicative r re rep repl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 [,,,,,,,,, 10 10 0 1 0 0 1
transferase (TdT), transferase t tr tra tran BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (),][,]. 8 9 0 1 0 0 1
structure, with structure, s st str stru BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 9 0 1 0 0 1
variation among variation v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ; 1 9 0 1 0 0 1
preserved over preserved p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 9 0 1 0 0 1
that confer that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 .- 2 8 0 1 0 0 1
ogy, eukaryotic ogy, o og ogy ogy, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 ,, 2 9 0 1 0 0 1
A, B, a, A A, A, A, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 ,,,[]. 6 9 0 1 0 0 1
as pols as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ;,, 3 9 0 1 0 0 1
and e and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ;,, 3 10 0 1 0 0 1
TdT; and tdt; T Td TdT TdT; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ;,, 3 9 0 1 0 0 1
[9]. We [9]. [ [9 [9] [9]. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 []. 3 9 0 1 0 0 1
natural products natural n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 9 0 1 0 0 1
than 18 than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 [,]., 5 9 0 1 0 0 1
or K or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ,[,]. 5 7 0 1 0 0 1
Vitamin K vitamin V Vi Vit Vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 (,--,-, 7 8 0 1 0 0 1
Fig. 1) fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 .)- 3 9 0 1 0 0 1
principal chemical principal p pr pri prin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 8 0 1 0 0 1
compounds that compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 8 0 1 0 0 1
exchange of exchange e ex exc exch BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 --()- 5 8 0 1 0 0 1
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 .. 2 6 0 0 1 1 0
1 1 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 11 no 0 10 0 0 0 0 0
groups and groups g gr gro grou BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 7 1 1 0 0 1
resulting in resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 1 1 0 0 1
toxicological properties toxicological t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 1 0 0 1
agents, have agents, a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,., 3 8 1 1 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 1 0 0 1
species (ROS) species s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()[-]. 6 9 1 1 0 0 1
study, we study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,----,- 7 8 1 1 0 0 1
(plumbagin, 1 (plumbagin, ( (p (pl (plu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (,.), 5 8 1 1 0 0 1
skeleton and skeleton s sk ske skel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 1 1 0 0 1
C-2 positions, c-2 C C- C-2 C-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -,.() 5 9 1 1 0 0 1
the Plumbaginaceae, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,,- 4 8 1 1 0 0 1
cophyllaceae families. cophyllaceae c co cop coph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .() 3 9 1 1 0 0 1
of Plumbago of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .('''').() 10 9 1 1 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -,-, 4 9 1 1 0 0 1
and anti-microbial and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -[-]... 7 9 1 1 0 0 1
been used been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 1 0 0 1
its components its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -,,- 4 9 1 1 0 0 1
tective, and tective, t te tec tect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,[].() 6 9 1 1 0 0 1
potent anti-proliferative potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 10 1 1 0 0 1
human cancers, human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 1 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -[]. 4 5 1 1 0 0 1
We previously we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 (),(- 5 9 1 1 0 0 1
hydroxy-1,4-naphthoquinone, 4 hydroxy-1,4-naphthoquinone, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -,-,.), 7 9 1 1 0 0 1
acids such acids a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --(-.) 6 9 1 1 0 0 1
inhibitors than inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()[],,-- 8 9 1 1 0 0 1
derivatives of derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (-.) 4 8 1 1 0 0 1
synthesized from synthesized s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 () 2 8 1 1 0 0 1
5-O-acyl juglones 5-o-acyl 5 5- 5-O 5-O- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 --(-)., 7 9 1 1 0 0 1
stability of stability s st sta stab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 --()--(). 9 9 1 1 0 0 1
also assayed also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --(- 4 9 1 1 0 0 1
j) on j) j j) j) j) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ), 2 9 1 1 0 0 1
lines and lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -() 3 9 1 1 0 0 1
and 5-O-acyl and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --(). 5 8 1 1 0 0 1
inhibitory and inhibitory i in inh inhi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -- 2 10 0 1 0 0 1
derivatives is derivatives d de der deri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 4 0 1 0 0 1
Materials and materials M Ma Mat Mate BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 1 0 0 1
Materials Materials materials M Ma Mat Mate BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
A chemically a A A A A BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 4 ,(), 4 8 0 0 0 0 1
purchased from purchased p pu pur purc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -.() 4 9 0 0 0 0 1
DNA primer dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 -.. 3 8 0 0 0 0 1
(Hokkaido, Japan). (hokkaido, ( (H (Ho (Hok BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (,).[]--- 9 10 0 0 0 0 1
ythymidine-59-triphosphate (dTTP; ythymidine-59-triphosphate y yt yth ythy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 --(;/) 6 9 0 0 0 0 1
from Moravek from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 .(,,). 6 8 0 0 0 0 1
reagents were reagents r re rea reag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 . 1 9 0 0 0 0 1
(Kyoto, Japan). (kyoto, ( (K (Ky (Kyo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (,). 4 2 0 0 0 0 1
Enzymes Enzymes enzymes E En Enz Enzy BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 10 0 0 0 0 1
Pol a pol P Po Pol Pol BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
chromatography as chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .[]. 4 9 0 0 0 0 1
rat pol rat r ra rat rat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
Date et date D Da Dat Date BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 .[]. 4 9 0 0 0 0 1
pFastBac. Histidine-tagged pfastbac. p pF pFa pFas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 .- 2 8 0 0 0 0 1
BACTO-BAC HT bacto-bac B BA BAC BACT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
the manufacturer's the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 '(,, 4 9 0 0 0 0 1
MD, USA) md, M MD MD, MD, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ,)(, 4 9 0 0 0 0 1
Tokyo Japan) tokyo T To Tok Toky BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 )[]. 4 9 0 0 0 0 1
fractionation of fractionation f fr fra frac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (-) 3 9 0 0 0 0 1
using the using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
chromatography, respectively chromatography, c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,[]. 4 8 0 0 0 0 1
pol g pol p po pol pol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (-)- 4 9 0 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 10 0 0 0 0 1
al. [28]. al. a al al. al. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 .[].- 5 9 0 0 0 0 1
terminal was terminal t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 7 0 0 0 0 1
chromatography [29]. chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 [].(- 5 8 0 0 0 0 1
560) with 560) 5 56 560 560) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 )--- 4 8 0 0 0 0 1
pressed in pressed p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..[]. 5 10 0 0 0 0 1
Recombinant human recombinant R Re Rec Reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .[]. 4 8 0 0 0 0 1
Recombinant human recombinant R Re Rec Reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 -. 2 9 0 0 0 0 1
and purified and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (- 2 9 0 0 0 0 1
Science Corp., science S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 .,,,) 5 8 0 0 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
[31]. Pol [31]. [ [3 [31 [31] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [].,, 5 10 0 0 0 0 1
inflorescence structure inflorescence i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
Sakaguchi et sakaguchi S Sa Sak Saka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 5 .[].(.. 7 8 0 0 0 0 1
Nipponbare) pol nipponbare) N Ni Nip Nipp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 )- 2 8 0 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .. 2 9 0 0 0 0 1
[33]. Calf [33]. [ [3 [33 [33] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [].,,,, 7 8 0 0 0 0 1
polynucleotide kinase polynucleotide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
(Kyoto, Japan). (kyoto, ( (K (Ky (Kyo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (,).. 5 9 0 0 0 0 1
purchased from purchased p pu pur purc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .(,, 4 8 0 0 0 0 1
USA). Bovine usa). U US USA USA) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ). 2 8 0 0 0 0 1
Stratagene Cloning stratagene S St Str Stra BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 (,,). 5 7 0 0 0 0 1
Measurement of measurement M Me Mea Meas BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 10 1 0 0 0 1
The reaction the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ,,, 3 9 1 0 0 0 1
prokaryotic pols prokaryotic p pr pro prok BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 [,]; 4 9 1 0 0 0 1
pol c pol p po pol pol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 .[].[],.,, 10 10 1 0 0 0 1
and k and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 9 1 0 0 0 1
the same the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 .,()/() 7 9 1 0 0 0 1
(A/T, 2/1) (a/t, ( (A (A/ (A/T BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 (/,/)- 6 8 1 0 0 0 1
substrate and substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 (;---- 6 8 1 0 0 0 1
phate) substrate, phate) p ph pha phat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 ),.,() 6 9 1 0 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 .(),--(), 9 10 1 0 0 0 1
vitamin K vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 (),(),--().'''' 15 10 1 0 0 0 1
represents a represents r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 -- 2 9 1 0 0 0 1
plumbagins (2) plumbagins p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 ()--(). 7 6 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g001 doi:10.1371/journal.pone.0088736.g001 doi:10.1371/journal.pone.0088736.g001 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 1 11 :./... 6 6 1 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 .. 2 6 1 0 1 0 0
2 2 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 0 1 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 11 no 0 10 1 0 0 0 0
(39-OH) and (39-oh) ( (3 (39 (39- BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 8 0 1 0 0 1
nucleotide substrate, nucleotide n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,. 2 5 0 1 0 0 1
The chemically the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 --(-) 5 8 0 1 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 8 0 1 0 0 1
concentrations and concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 10 0 1 0 0 1
were mixed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.) 3 8 0 1 0 0 1
Tris-HCl at tris-hcl T Tr Tri Tris BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 -.,, 4 9 0 1 0 0 1
(by vol), (by ( (b (by (by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (),. 4 9 0 1 0 0 1
0uC for 0uc 0 0u 0uC 0uC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .- 2 9 0 1 0 0 1
were next were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
and incubated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 9 0 1 0 0 1
incubated at incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 0 1 0 0 1
considered 100%, considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 1 0 0 1
each inhibitor each e ea eac each BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 1 0 0 1
as the as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
1 nmol 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 , 1 9 0 1 0 0 1
37uC, and 37uc, 3 37 37u 37uC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ,[,]. 5 8 0 1 0 0 1
Other enzyme other O Ot Oth Othe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
The activities the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 ,, 2 9 0 0 0 0 1
mouse inosine-59-triphosphate mouse m mo mou mous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 --()(), 7 10 0 0 0 0 1
polynucleotide kinase, polynucleotide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 , 1 9 0 0 0 0 1
measured in measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ' 1 9 0 0 0 0 1
specifications, as specifications, s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,-.[], 6 9 0 0 0 0 1
Nakayama and nakayama N Na Nak Naka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 [],.[], 7 9 0 0 0 0 1
al. [40], al. a al al. al. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 .[],[],. 8 7 0 0 0 0 1
Thermal transition thermal T Th The Ther BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 10 0 0 0 0 1
Thermal transition thermal T Th The Ther BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 9 0 0 0 0 1
with or with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 9 0 0 0 0 1
tometer (UV-2500; tometer t to tom tome BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 (-;.,,) 7 9 0 0 0 0 1
a thermoelectric a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 2 []. 3 10 0 0 0 0 1
Calf thymus calf C Ca Cal Calf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 (/). 4 8 0 0 0 0 1
phosphate buffer phosphate p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (.). 4 9 0 0 0 0 1
temperature was temperature t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 8 0 0 0 0 1
increased by increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -. 2 9 0 0 0 0 1
Any change any A An Any Any BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 () 2 9 0 0 0 0 1
each temperature each e ea eac each BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 10 0 0 0 0 1
DNA plus dna D DN DNA DNA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 . 1 7 0 0 0 0 1
Cell culture cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 10 0 0 0 0 1
The following the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
American Type american A Am Ame Amer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 (,,): 5 8 0 0 0 0 1
(A549), prostate (a549), ( (A (A5 (A54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 (),(),(-), 10 9 0 0 0 0 1
cervix (HeLa), cervix c ce cer cerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (),(),(-), 10 9 0 0 0 0 1
pancreatic cancer pancreatic p pa pan panc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (-). 4 9 0 0 0 0 1
1640 medium 1640 1 16 164 1640 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 3 , 1 8 0 0 0 0 1
penicillin (100 penicillin p pe pen peni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (/),(/), 8 8 0 0 0 0 1
1.6 mg/mL 1.6 1 1. 1.6 1.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 ./ 2 8 0 0 0 0 1
CO 2 co C CO CO CO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 2 3 /., 3 10 0 0 0 0 1
1610 3 1610 1 16 161 1610 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 3 /-- 3 9 0 0 0 0 1
tions of tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ,.(-(,- 7 9 0 0 0 0 1
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium dimethylthiazol-2-yl)-2,5-diphenyl d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 --)-,-) 7 9 0 0 0 0 1
was added was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ./- 3 9 0 0 0 0 1
water for water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 [], 3 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 8 0 0 0 0 1
microplate reader microplate m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (,-,, 5 9 0 0 0 0 1
CA, USA). ca, C CA CA, CA, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ,). 3 1 0 0 0 0 1
In vivo in I In In In BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 5 - 1 10 0 0 0 0 1
Male BALB/c male M Ma Mal Male BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 //() 4 8 0 0 0 0 1
purchased from purchased p pu pur purc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ,.(,). 6 10 0 0 0 0 1
standard laboratory standard s st sta stan BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 0 0 0 1
for 1 for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 8 0 1 0 0 1
experiments, human experiments, e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ,-(/) 5 9 0 1 0 0 1
subcutaneously injected subcutaneously s su sub subc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 . 1 9 0 1 0 0 1
that had that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ( 1 8 0 1 0 0 1
volume = volume v vo vol volu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ) 1 8 0 1 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 -. 2 8 0 1 0 0 1
divided randomly divided d di div divi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (/). 4 9 0 1 0 0 1
groups was groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 8 0 1 0 0 1
buffered saline buffered b bu buf buff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (), 3 9 0 1 0 0 1
vitamin K vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (),(),:-(),:- 13 10 0 1 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ()/. 4 9 0 1 0 0 1
administrations all administrations a ad adm admi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 - 1 9 0 1 0 0 1
implantation. All implantation. i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 .- 2 9 0 1 0 0 1
day intervals day d da day day BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 (). 3 9 0 1 0 0 1
growth was growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 - 1 8 0 1 0 0 1
implantation. At implantation. i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 .-, 3 9 0 1 0 0 1
mice treated mice m mi mic mice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 - 1 8 0 1 0 0 1
dently examined dently d de den dent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ,, 2 8 0 1 0 0 1
spleen, stomach, spleen, s sp spl sple BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ,,,,,,. 7 9 0 1 0 0 1
This animal this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 8 0 1 0 0 1
Care and care C Ca Car Care BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 0 1 0 0 1
performed according performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 1 0 0 1
Use of use U Us Use Use BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 8 0 1 0 0 1
animals were animals a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 1 0 0 1
cervical dislocation. cervical c ce cer cerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 .- 2 9 0 1 0 0 1
free access free f fr fre free BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 . 1 9 0 1 0 0 1
the mice the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 -/ 2 8 0 1 0 0 1
housed at housed h ho hou hous BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 5 0 1 0 0 1
Analytical instruments analytical A An Ana Anal BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 -- 2 10 0 0 0 0 1
(2a-j) (2a-j) (2a-j) ( (2 (2a (2a- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 (-) 3 1 0 0 0 0 1
Melting points, melting M Me Mel Melt BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 , 1 8 0 0 0 0 1
apparatus, are apparatus, a ap app appa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ,. 2 8 0 0 0 0 1
Bruker spectrometer bruker B Br Bru Bruk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
in d in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 (), 3 9 0 0 0 0 1
coupling constants coupling c co cou coup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
abbreviations are abbreviations a ab abb abbr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 :,, 3 10 0 0 0 0 1
t = t t t t t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 8 ,,,,. 5 9 0 0 0 0 1
Infrared spectra infrared I In Inf Infr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 ()-, 4 8 0 0 0 0 1
NaCl (neat) nacl N Na NaC NaCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 ()()- 5 8 0 0 0 0 1
bers (cm bers b be ber bers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ().() 5 9 0 0 0 0 1
on a on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (-) 3 8 0 0 0 0 1
bombardment (FAB), bombardment b bo bom bomb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (),- 4 8 0 0 0 0 1
resonance-mass spectrometer, resonance-mass r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -,(--) 6 8 0 0 0 0 1
using electrospray using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 () 2 9 0 0 0 0 1
(LDI) techniques. (ldi) ( (L (LD (LDI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 ().-() 6 8 0 0 0 0 1
was performed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
chromatography was chromatography c ch chr chro BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 ----- 5 10 0 0 0 0 1
1,4-naphthoquinone (C2:0-Acyl 1,4-naphthoquinone 1 1, 1,4 1,4- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,-(:-,) 7 8 0 0 0 0 1
Acetic anhydride acetic A Ac Ace Acet BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 (.) 3 9 0 0 0 0 1
(1) (107 (1) ( (1 (1) (1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ()(,.)(.), 10 9 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
removed, the removed, r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 , 1 9 0 0 0 0 1
(EtOAc/hexanes 1:3, (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 (/:,/)(,) 9 9 0 0 0 0 1
solid [44]. solid s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 [].-;(),,,, 11 8 0 0 0 0 1
1761, 1662, 1761, 1 17 176 1761 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 9 ,,,,,,,,,, 10 8 0 0 0 0 1
785 cm 785 7 78 785 785 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 ;(,).(,., 9 9 0 0 0 0 1
0.8 Hz, 0.8 0 0. 0.8 0.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .,),.(,.,),.(,., 16 8 0 0 0 0 1
0.8 Hz, 0.8 0 0. 0.8 0.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .,),.(,.,),.(,),.(, 19 8 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 .,);(,).,., 11 8 0 0 0 0 1
169.4, 149.2, 169.4, 1 16 169 169. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .,.,.,.,.,.,.,.,.,., 20 10 0 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 .. 2 6 0 0 1 0 0
3 3 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 11 no 0 10 0 0 0 0 0
16.0; HRMS 16.0; 1 16 16. 16.0 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .;()([])., 10 10 1 0 0 0 1
found 253.0482 found f fo fou foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 2 1 0 0 0 1
General procedure general G Ge Gen Gene BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 10 1 0 0 0 1
plumbagins (2b-f) plumbagins p pl plu plum BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (-) 3 5 1 0 0 0 1
Et 3 et E Et Et Et BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 (.-..),--- 10 8 0 0 0 0 1
(MNBA) (1.5 (mnba) ( (M (MN (MNB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 ()(..),---() 12 8 0 0 0 0 1
(0.1 equiv.) (0.1 ( (0 (0. (0.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 (..)()(..) 10 9 0 0 0 0 1
and carboxylic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 (..). 5 9 0 0 0 0 1
The mixture the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 8 0 0 0 0 1
atmosphere until atmosphere a at atm atmo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 . 1 8 0 0 0 0 1
reaction was reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 , 1 9 0 0 0 0 1
was extracted was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 . 1 8 0 0 0 0 1
with brine, with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ,,. 3 10 0 0 0 0 1
purified by purified p pu pur puri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 / 1 10 1 0 0 0 1
eluent. eluent. eluent. e el elu elue BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 . 1 1 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 ---- 4 10 1 0 0 0 1
methyl-1,4-naphthoquinone (C3:0-Acyl methyl-1,4-naphthoquinone m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 -,-(:-,) 8 9 1 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 ,() 3 9 0 0 0 0 1
(52 mg, (52 ( (5 (52 (52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 (,.)(,.) 8 9 0 0 0 0 1
MNBA (143 mnba M MN MNB MNBA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 (,.),(,.), 10 8 0 0 0 0 1
DMAP (3.4 dmap D DM DMA DMAP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 (.,.). 6 9 0 0 0 0 1
crude product crude c cr cru crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
(EtOAc/hexanes = (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (//,/)(,) 9 9 0 0 0 0 1
solid [44]. solid s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 [].-;(),,,, 11 9 0 0 0 0 1
1766, 1662, 1766, 1 17 176 1766 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 5 ,,,,,,,,,,, 11 10 0 0 0 0 1
881, 781 881, 8 88 881 881, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,;(,).(, 8 8 0 0 0 0 1
J = j J J J J BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 5 .,.,),.(,.,),.(, 16 9 0 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 .--(-).()--().()--(-).() 24 10 1 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 --(-). 6 2 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g002 doi:10.1371/journal.pone.0088736.g002 doi:10.1371/journal.pone.0088736.g002 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 9 :./... 6 2 1 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 .. 2 6 0 0 1 0 0
4 4 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 11 no 0 10 0 0 0 0 0
J = j J J J J BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 .,.,),.(,.,),.(, 16 9 1 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 .,),.(,.,),.(,., 16 9 1 0 0 0 1
3H); 13 3h); 3 3H 3H) 3H); BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 );(,).,.,.,., 13 9 1 0 0 0 1
146.8, 136.9, 146.8, 1 14 146 146. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,.,.,.,.,.,.,.,.,.; 20 10 1 0 0 0 1
HRMS (FAB) hrms H HR HRM HRMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ()([])., 8 10 1 0 0 0 1
267.0639. 267.0639. 267.0639. 2 26 267 267. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .. 2 1 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 ---- 4 10 0 0 0 0 1
methyl-1,4-naphthoquinone (C6:0-Acyl methyl-1,4-naphthoquinone m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 -,-(:-,) 8 10 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 ,() 3 9 0 0 0 0 1
(100 mg, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 (,.)(,.) 8 9 0 0 0 0 1
MNBA (274 mnba M MN MNB MNBA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 (,.),(,.), 10 8 0 0 0 0 1
DMAP (6.7 dmap D DM DMA DMAP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 (.,.). 6 9 0 0 0 0 1
crude product crude c cr cru crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
(EtOAc/hexanes = (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (//,/)(,) 9 9 0 0 0 0 1
solid. Mp solid. s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 .-;(),,,,, 10 9 0 0 0 0 1
1664, 1631, 1664, 1 16 166 1664 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 1 ,,,,,,,,,,, 11 9 0 0 0 0 1
791 cm 791 7 79 791 791 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 1 ;(,).(,., 9 9 0 0 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .,),.(,.,),.(,., 16 9 0 0 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .,),.(,.,),.(,.,), 18 10 0 0 0 0 1
2.09 (d, 2.09 2 2. 2.0 2.09 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .(,.,),.(,.,),.-. 17 10 0 0 0 0 1
(m, 4H), (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (,),.(,.,);(,) 14 10 0 0 0 0 1
184.9, 183.6, 184.9, 1 18 184 184. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .,.,.,.,.,.,.,.,., 18 9 0 0 0 0 1
125.0, 123.6, 125.0, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .,.,.,.,.,.,.,.;() 18 9 0 0 0 0 1
calcd for calcd c ca cal calc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 ([]).,.. 8 10 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 ---- 4 10 1 0 0 0 1
methyl-1,4-naphthoquinone (C12:0-Acyl methyl-1,4-naphthoquinone m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -,-(:-,) 8 9 1 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 ,() 3 9 1 0 0 0 1
(53 mg, (53 ( (5 (53 (53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (,.)(,.) 8 8 1 0 0 0 1
MNBA (147 mnba M MN MNB MNBA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 (,.),(,.), 10 8 1 0 0 0 1
DMAP (3.5 dmap D DM DMA DMAP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 (.,.). 6 9 1 0 0 0 1
crude product crude c cr cru crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 1 0 0 0 1
(EtOAc/hexanes = (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (//,/)(,) 9 9 1 0 0 0 1
crystal; Mp crystal; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ;-;(),,,,, 10 8 1 0 0 0 1
1593, 1464, 1593, 1 15 159 1593 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 5 ,,,,,,,,,, 10 8 1 0 0 0 1
787 cm 787 7 78 787 787 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 5 ;(,).(,., 9 9 1 0 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,),.(,.,),.(,., 16 8 1 0 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,),.(,.,),.(,.,), 18 9 1 0 0 0 1
2.16 (d, 2.16 2 2. 2.1 2.16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .(,.,),.(,.,),.-. 17 9 1 0 0 0 1
(brm, 16H), (brm, ( (b (br (brm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (,),.(,.,);(, 13 8 1 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ).,.,.,.,.,.,.,., 17 9 1 0 0 0 1
129.5, 125.0, 129.5, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.,.,.(),.,.,.,., 22 10 1 0 0 0 1
24.4, 22.7, 24.4, 2 24 24. 24.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.;(-) 11 9 1 0 0 0 1
([M+Na] + ([m+na] ( ([ ([M ([M+ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ([]).,.. 8 5 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 --- 3 10 0 0 0 0 1
2-methyl-1,4-naphthoquinone (C18:0-Acyl 2-methyl-1,4-naphthoquinone 2 2- 2-m 2-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 --,-(:-, 8 9 0 0 0 0 1
2e) 2e) 2e) 2 2e 2e) 2e) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 ) 1 0 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 ,() 3 9 0 0 0 0 1
(102 mg, (102 ( (1 (10 (102 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 (,.)(,.) 8 10 0 0 0 0 1
MNBA (280 mnba M MN MNB MNBA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 9 (,.),(,.), 10 9 0 0 0 0 1
DMAP (6.6 dmap D DM DMA DMAP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 9 (.,.). 6 9 0 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 .:-():-().:-()() 16 9 1 0 0 0 1
C18:1-acyl juglone c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 :-()(),-.- 10 10 1 0 0 0 1
over time. over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 .:.,,. 6 4 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g003 doi:10.1371/journal.pone.0088736.g003 doi:10.1371/journal.pone.0088736.g003 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 10 :./... 6 2 1 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 .. 2 6 0 0 1 0 0
5 5 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 4 11 no 0 10 0 0 0 0 0
crude product crude c cr cru crud BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
(EtOAc/hexanes = (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (//,/)(,) 9 8 1 0 0 0 1
yellow solid. yellow y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .-;(),,,, 9 8 1 0 0 0 1
1593, 1541, 1593, 1 15 159 1593 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 0 ,,,,,,,,; 9 9 1 0 0 0 1
NMR (400 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (,).(,.,.,), 12 8 1 0 0 0 1
7.65 (t, 7.65 7 7. 7.6 7.65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,.,),.(,.,.,),.(, 19 10 1 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 .,),.(,.,),.(,.,), 18 9 1 0 0 0 1
1.74 (quin, 1.74 1 1. 1.7 1.74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,.,),.-.(,),.(, 17 8 1 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 .,);(,).,,, 11 8 1 0 0 0 1
172.2, 149.4, 172.2, 1 17 172 172. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.,.,.,.,.,.,.,.,., 20 9 1 0 0 0 1
31.9, 29.7 31.9, 3 31 31. 31.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.(),.(),.,.,.,.,.,.,., 24 10 1 0 0 0 1
16.0, 14.1; 16.0, 1 16 16. 16.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.;()([]) 10 8 1 0 0 0 1
477.2981, found 477.2981, 4 47 477 477. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 0 .,.. 4 3 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 ----- 5 10 0 0 0 0 1
1,4-naphthoquinone (C18:1-Acyl 1,4-naphthoquinone 1 1, 1,4 1,4- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,-(:-,) 7 8 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 ,() 3 9 0 0 0 0 1
(100 mg, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 (,.)(.,.) 9 9 0 0 0 0 1
MNBA (275 mnba M MN MNB MNBA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.),(,.), 10 8 0 0 0 0 1
DMAP (6.5 dmap D DM DMA DMAP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 (.,.). 6 9 0 0 0 0 1
crude product crude c cr cru crud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
(EtOAc/hexanes = (etoac/hexanes ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (//,/)(,) 9 9 0 0 0 0 1
oil. IR oil. o oi oil oil. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 .(),,,,,,,, 11 9 0 0 0 0 1
1271, 1190, 1271, 1 12 127 1271 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 3 ,,,,;(,) 8 9 0 0 0 0 1
8.06 (dd, 8.06 8 8. 8.0 8.06 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .(,.,.,),.(,.,),. 17 10 0 0 0 0 1
(dd, J (dd, ( (d (dd (dd, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.,.,),.(,.,),.-. 18 10 0 0 0 0 1
(m, 2H), (m, ( (m (m, (m, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,),.(,.,),.(,.,),.- 20 10 0 0 0 0 1
1.97 (brm, 1.97 1 1. 1.9 1.97 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .(,),.(,.,),.-.(,), 19 9 1 0 0 0 1
0.88 (t, 0.88 0 0. 0.8 0.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .(,.,);(,)., 12 9 1 0 0 0 1
183.6, 172.1, 183.6, 1 18 183 183. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .,.,.,.,.,.,.,.,., 18 9 1 0 0 0 1
129.5, 125.0, 129.5, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .,.,.,.,.,.,.,.,.,.,., 22 10 1 0 0 0 1
29.2, 29.1, 29.2, 2 29 29. 29.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .,.,.,.,.,.,.,.;() 18 9 1 0 0 0 1
for C for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ([]).,.. 8 8 1 0 0 0 1
General procedure general G Ge Gen Gene BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 0 0 0 0 1
plumbagins (2g-j) plumbagins p pl plu plum BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (-) 3 8 0 0 0 0 1
Oxalyl chloride oxalyl O Ox Oxa Oxal BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (.-..) 6 8 0 0 0 0 1
carboxylic acid carboxylic c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (.). 4 9 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -.. 3 9 0 0 0 0 1
to yield to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .(.-. 5 10 0 0 0 0 1
equiv.), plumbagin equiv.), e eq equ equi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 .),()(.)(..) 12 8 0 0 0 0 1
pyridine was pyridine p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 . 1 9 0 0 0 0 1
at room at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
changes were changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 . 1 7 0 0 0 0 1
addition of addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ,. 2 9 0 0 0 0 1
extracts were extracts e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ,, 2 8 0 0 0 0 1
concentrated. The concentrated. c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .- 2 8 0 0 0 0 1
raphy using raphy r ra rap raph BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 /. 2 6 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 ---- 4 10 0 0 0 0 1
methyl-1,4-naphthoquinone (C18:2-Acyl methyl-1,4-naphthoquinone m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 -,-(:-,) 8 10 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 , 1 8 0 0 0 0 1
prepared by prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (,.) 4 10 0 0 0 0 1
oxalyl chloride oxalyl o ox oxa oxal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 (,.). 5 9 0 0 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 .()--(-). 9 8 1 0 0 0 1
(10 mM) (10 ( (1 (10 (10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 ()(-),(-),(-),(-)(. 19 9 1 0 0 0 1
units each). units u un uni unit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ).(),. 6 10 1 0 0 0 1
6 SD 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 10 ().**,.*,... 12 3 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g004 doi:10.1371/journal.pone.0088736.g004 doi:10.1371/journal.pone.0088736.g004 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 10 :./... 6 2 1 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 .. 2 6 0 0 1 0 0
6 6 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 11 no 0 10 0 0 0 0 0
plumbagin (1) plumbagin p pl plu plum BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ()(,.) 6 8 1 1 0 0 1
chloride using chloride c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (.,.) 5 8 1 1 0 0 1
gave the gave g ga gav gave BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 1 1 0 0 1
gel column gel g ge gel gel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (//,/) 6 9 1 1 0 0 1
2g (31.9 2g 2 2g 2g 2g BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (.,).(),,,, 11 9 1 1 0 0 1
1664, 1595, 1664, 1 16 166 1664 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ,,,,,,,,,, 10 8 1 1 0 0 1
783 cm 783 7 78 783 783 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ;(,).(,., 9 9 1 1 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,),.(,.,),.(,., 16 8 1 1 0 0 1
1.2 Hz, 1.2 1 1. 1.2 1.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,),.(,.,),.-.(,),.(, 21 9 1 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 .,),.(,.,),.(,.,), 18 10 1 1 0 0 1
2.08-2.03 (m, 2.08-2.03 2 2. 2.0 2.08 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .-.(,),.(,.,),.-.(, 19 8 1 1 0 0 1
14H), 0.94-0.86 14h), 1 14 14H 14H) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ),.-.(,);(,)., 14 8 1 1 0 0 1
183.6, 172.2, 183.6, 1 18 183 183. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,., 18 9 1 1 0 0 1
129.5, 128.0, 129.5, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,.,., 20 9 1 1 0 0 1
29.3, 29.2, 29.3, 2 29 29. 29.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,.,.,.;() 20 9 1 1 0 0 1
calcd for calcd c ca cal calc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ([]).,.. 8 9 1 1 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ---- 4 10 1 1 0 0 1
metyl-1,4-naphthoquinone (C18:3-Acyl metyl-1,4-naphthoquinone m me met mety BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 -,-(:-,) 8 9 1 1 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ,- 2 8 1 1 0 0 1
prepared by prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(,.) 5 8 1 1 0 0 1
with oxalyl with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (,.).. 6 9 1 1 0 0 1
of plumbagin of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ()(,.)- 7 9 1 1 0 0 1
chloride using chloride c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (.,.) 5 8 1 1 0 0 1
gave the gave g ga gav gave BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 9 1 1 0 0 1
gel column gel g ge gel gel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (//,/) 6 8 1 1 0 0 1
2h (32 2h 2 2h 2h 2h BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (,);(),,,, 10 9 1 1 0 0 1
1664, 1595, 1664, 1 16 166 1664 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 5 ,,,,,,,,; 9 8 1 1 0 0 1
NMR (400 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 (,).(,.,.,), 12 8 1 1 0 0 1
7.71 (t, 7.71 7 7. 7.7 7.71 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .(,.,),.(,.,.,),.(, 19 10 1 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 5 .,),.-.(,),.-.(,),.(, 21 9 1 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 5 .,),.-.(,),.(,),.-. 19 9 1 1 0 0 1
(brm, 8H), (brm, ( (b (br (brm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (,),.(,.,);(,) 14 9 1 1 0 0 1
d 184.9, d d d d d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 5 .,.,.,.,.,.,.,.,., 18 9 1 1 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 .()--(-). 9 9 1 1 0 0 1
compound (10 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ()., 4 9 1 1 0 0 1
determined by determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 .(). 4 10 1 1 0 0 1
shown as shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ().**,.*,... 12 4 1 1 0 0 1
doi:10.1371/journal.pone.0088736.g005 doi:10.1371/journal.pone.0088736.g005 doi:10.1371/journal.pone.0088736.g005 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 9 :./... 6 2 1 1 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 .. 2 6 0 0 1 0 0
7 7 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 6 11 no 0 10 0 0 0 0 0
130.3, 130.0, 130.3, 1 13 130 130. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.(),.,.,.,.,.,., 20 9 1 0 0 0 1
29.2, 29.1, 29.2, 2 29 29. 29.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.,.,.,.,.,.,.; 20 9 1 0 0 0 1
(FAB) calcd (fab) ( (F (FA (FAB BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ()([]).,.. 10 10 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 -- 2 7 0 0 0 0 1
eicosapentaenoyloxy-2-methyl-1,4-naphthoquinone eicosapentaenoyloxy-2-methyl-1,4-naphthoquinone eicosapentaenoyloxy-2-methyl-1,4-naphthoquinone e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 ---,- 5 10 0 0 0 0 1
(C20:5-Acyl plumbagin, (c20:5-acyl ( (C (C2 (C20 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 (:-,) 5 5 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 9 0 0 0 0 1
prepared by prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (, 2 8 0 0 0 0 1
0.64 mmol) 0.64 0 0. 0.6 0.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .)(,.). 7 9 0 0 0 0 1
The reaction the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 ()(,.) 6 9 0 0 0 0 1
eicosapentaenoyl chloride eicosapentaenoyl e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 (.,.) 5 9 0 0 0 0 1
pyridine for pyridine p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (/- 3 8 0 0 0 0 1
anes = anes a an ane anes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 /,/)().() 9 9 0 0 0 0 1
3012, 2962, 3012, 3 30 301 3012 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 ,,,,,,,,,,, 11 10 0 0 0 0 1
783, 717 783, 7 78 783 783, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 ,;(,).(, 8 8 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 1 .,.,),.(,.,),.(, 16 9 0 0 0 0 1
J = j J J J J BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 1 .,.,),.(,.,),.-.(, 18 10 0 0 0 0 1
10H), 2.90-2.72 10h), 1 10 10H 10H) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 ),.-.(,),.(,.,),.(, 19 8 1 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 .,),.(,.,),.(, 14 8 1 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 .,),.(,.,);(, 13 8 1 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ).,.,.,.,.,.,.,., 17 9 1 0 0 0 1
132.0, 129.4, 132.0, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .,.,.,.,.,.,.,.,., 18 9 1 0 0 0 1
127.8, 127.0, 127.8, 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .,.,.,.,.,.,.,.,.,.,., 22 10 1 0 0 0 1
20.5, 16.1, 20.5, 2 20 20. 20.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .,.,.;(-) 9 8 1 0 0 0 1
([M+Na] + ([m+na] ( ([ ([M ([M+ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ([]).,.. 8 5 1 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 -- 2 8 0 0 0 0 1
docosahexaenoyloxy-2-methyl-1,4-naphthoquinone docosahexaenoyloxy-2-methyl-1,4-naphthoquinone docosahexaenoyloxy-2-methyl-1,4-naphthoquinone d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 ---,- 5 10 0 0 0 0 1
(C22:6-Acyl plumbagin, (c22:6-acyl ( (C (C2 (C22 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 (:-,) 5 5 0 0 0 0 1
Following the following F Fo Fol Foll BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 , 1 9 0 0 0 0 1
prepared by prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 (, 2 8 0 0 0 0 1
0.64 mmol) 0.64 0 0. 0.6 0.64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .)(,.). 7 9 0 0 0 0 1
The reaction the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 ()(,.) 6 10 0 0 0 0 1
docosahexaenoyl chloride docosahexaenoyl d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 (.,.) 5 9 0 0 0 0 1
pyridine for pyridine p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 (/- 3 8 0 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 . 1 9 1 0 0 0 1
(1) and (1) ( (1 (1) (1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 ()--(-).-.(),(),() 18 9 1 0 0 0 1
human pol human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ,().-. 6 10 1 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 .;. 3 5 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g006 doi:10.1371/journal.pone.0088736.g006 doi:10.1371/journal.pone.0088736.g006 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 9 :./... 6 2 1 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 .. 2 6 0 0 1 0 0
8 8 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 6 11 no 0 10 0 0 0 0 0
anes = anes a an ane anes BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 /,/)(,);() 10 9 0 1 0 0 1
3012, 2964, 3012, 3 30 301 3012 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ,,,,,,,,,, 10 8 0 1 0 0 1
1128, 1026, 1128, 1 11 112 1128 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 ,,,,,;(, 8 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ).(,.,.,),.(,., 15 9 0 1 0 0 1
1H), 7.35 1h), 1 1H 1H) 1H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ),.(,.,.,),.(,.,), 18 9 0 1 0 0 1
5.34 (m, 5.34 5 5. 5.3 5.34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(,),.-.(,),.(,.,),. 20 9 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,.,),.(,.,),.(, 16 8 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 .,);(,).,., 11 8 0 1 0 0 1
171.5, 149.3, 171.5, 1 17 171 171. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.,.,.,.,.,., 18 9 0 1 0 0 1
128.5, 128.2 128.5, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.(),.,.,.,.,.,.,., 20 10 0 1 0 0 1
125.1, 123.5, 125.1, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.,.,.,.,.,.,.,., 22 10 0 1 0 0 1
14.3; HRMS 14.3; 1 14 14. 14.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .;(-)([]) 9 8 0 1 0 0 1
521.2662, found 521.2662, 5 52 521 521. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 .,.. 4 3 0 1 0 0 1
Stability of stability S St Sta Stab BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 2 :-():- 6 10 0 1 0 0 1
juglone (5f) juglone j ju jug jugl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 () 2 6 0 1 0 0 1
A 2.2610 a A A A A BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 7 2 . 1 8 0 0 0 0 1
2.2610 22 2.2610 2 2. 2.2 2.26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 2 .,-., 5 9 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,- 2 9 0 0 0 0 1
1.1610 23 1.1610 1 1. 1.1 1.16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 2 .., 3 8 0 0 0 0 1
monitored by monitored m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -.- 3 9 0 0 0 0 1
at 25uC at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -(-,, 5 9 0 0 0 0 1
Japan). For japan). J Ja Jap Japa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 ).,-. 5 9 0 0 0 0 1
of C18:1-acyl of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 :-(),:-(),- 11 10 0 0 0 0 1
dioxane and dioxane d di dio diox BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 (/,/). 6 6 0 0 0 0 1
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
All data all A Al All All BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 8 0 0 0 0 1
deviation (SD) deviation d de dev devi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 () 2 9 0 0 0 0 1
each experiment. each e ea eac each BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 .- 2 9 0 0 0 0 1
tal group tal t ta tal tal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 '-, 3 9 0 0 0 0 1
level of level l le lev leve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ... 3 10 0 0 0 0 1
Results and results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 --(-) 5 10 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 --(-).. 7 10 0 0 0 0 1
C2:0-Acyl plumbagin c2:0-acyl C C2 C2: C2:0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 :-() 4 8 0 0 0 0 1
plumbagin (1) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 () 2 9 0 0 0 0 1
(Fig. 2A). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (.).---- 8 9 0 0 0 0 1
sation of sation s sa sat sati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (), 3 10 0 0 0 0 1
using MNBA using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 (.). 4 9 0 0 0 0 1
5-O-Acyl plumbagins 5-o-acyl 5 5- 5-O 5-O- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 --- 3 8 0 0 0 0 1
plumbagin (1) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 () 2 9 0 0 0 0 1
pyridine (Fig. pyridine p py pyr pyri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 (.). 4 3 0 0 0 0 1
Stability of stability S St Sta Stab BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 5 :-():- 6 10 0 0 0 0 1
juglone (5f) juglone j ju jug jugl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 () 2 6 0 0 0 0 1
We have we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 :-() 4 8 0 0 0 0 1
than C18:1-acyl than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 :-()[].:- 9 9 0 0 0 0 1
acyl plumbagin acyl a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ():-() 6 9 0 0 0 0 1
Triton B triton T Tr Tri Trit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 (),- 4 8 0 0 0 0 1
and MeOH. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .., 3 8 0 0 0 0 1
recorded at recorded r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 9 0 0 0 0 1
spectra of spectra s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 :-() 4 9 0 0 0 0 1
after treatment after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 (.). 4 10 0 0 0 0 1
C18:1-acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 :-() 4 9 0 0 0 0 1
reaction. In reaction. r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .,:- 4 9 0 0 0 0 1
juglone (5f) juglone j ju jug jugl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ()(.). 6 9 0 0 0 0 1
675 nm 675 6 67 675 675 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 5 no 0 8 0 0 0 0 1
Triton B. triton T Tr Tri Trit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 . 1 9 0 0 0 0 1
extended aromatic extended e ex ext exte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 :- 2 8 0 0 0 0 1
juglone with juglone j ju jug jugl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ,-. 3 9 0 0 0 0 1
at 675 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 , 1 9 0 0 0 0 1
extended aromatic extended e ex ext exte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 8 0 0 0 0 1
400 nm 400 4 40 400 400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 5 . 1 8 0 0 0 0 1
broad absorption broad b br bro broa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -. 2 8 0 0 0 0 1
results suggest results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 :-() 4 9 0 0 0 0 1
under basic under u un und unde BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 . 1 3 0 0 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 --(-) 5 10 0 0 0 0 1
activities of activities a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 no 0 5 0 0 0 0 1
Initially, the initially, I In Ini Init BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 ,--(- 5 9 0 0 0 0 1
j) toward j) j j) j) j) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 ), 2 9 0 0 0 0 1
human pols human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ,,.,,,, 7 8 0 0 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ,,,, 4 9 0 0 0 0 1
respectively [8,9]. respectively r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 [,]. 4 10 0 0 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 .:-() 5 10 0 1 0 0 1
mammalian pols, mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ,, 2 8 0 1 0 0 1
metabolic enzymes. metabolic m me met meta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 . 1 2 0 1 0 0 1
Enzyme Enzyme enzyme E En Enz Enzy BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 3 0 1 0 0 1
IC 50 ic I IC IC IC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 9 () 2 10 0 1 0 0 1
-Mammalian pols -mammalian - -M -Ma -Mam BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 -- 2 10 0 1 0 0 1
[A family [a [ [A [A [A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 [] 2 10 0 1 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
4.560.40 ** 4.560.40 4 4. 4.5 4.56 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..** 4 10 0 0 0 0 1
[B family [b [ [B [B [B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 [] 2 10 0 0 0 0 1
Calf pol calf C Ca Cal Calf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 9 0 0 0 0 1
4.860.38 ** 4.860.38 4 4. 4.8 4.86 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..** 4 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
5.360.41 ** 5.360.41 5 5. 5.3 5.36 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..** 4 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
4.960.40 ** 4.960.40 4 4. 4.9 4.96 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..** 4 10 0 0 0 0 1
[X family [x [ [X [X [X BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 [] 2 10 0 0 0 0 1
Rat pol rat R Ra Rat Rat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 7 0 0 0 0 1
10.360.46 ** 10.360.46 1 10 10. 10.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..** 4 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
9.260.43 ** 9.260.43 9 9. 9.2 9.26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
9.560.48 ** 9.560.48 9 9. 9.5 9.56 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
Calf TdT calf C Ca Cal Calf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 6 0 0 0 0 1
10.660.50 ** 10.660.50 1 10 10. 10.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
[Y family [y [ [Y [Y [Y BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 [] 2 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
7.960.42 ** 7.960.42 7 7. 7.9 7.96 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
Mouse pol mouse M Mo Mou Mous BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
8.260.43 ** 8.260.43 8 8. 8.2 8.26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
Human pol human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
7.660.41 ** 7.660.41 7 7. 7.6 7.66 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..** 4 10 0 0 0 0 1
-Plant pol -plant - -P -Pl -Pla BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 -- 2 10 0 0 0 0 1
Cauliflower pol cauliflower C Ca Cau Caul BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 2 0 0 0 0 1
Rice pol rice R Ri Ric Rice BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 4 0 0 0 0 1
-Prokaryotic pols -prokaryotic - -P -Pr -Pro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 -- 2 10 0 0 0 0 1
E. coli e. E E. E. E. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 . 1 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 3 0 0 0 0 1
Taq pol taq T Ta Taq Taq BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 6 0 0 0 0 1
T4 pol t4 T T4 T4 T4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 7 0 0 0 0 1
-Other DNA -other - -O -Ot -Oth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 -- 2 10 0 0 0 0 1
Calf primase calf C Ca Cal Calf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 0 0 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 . 1 2 0 0 0 0 1
T7 RNA t7 T T7 T7 T7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 . 1 2 0 1 0 0 1
Mouse IMP mouse M Mo Mou Mous BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 () 2 10 0 1 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 . 1 1 0 1 0 0 1
T4 polynucleotide t4 T T4 T4 T4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 . 1 2 0 1 0 0 1
Bovine deoxyribonuclease bovine B Bo Bov Bovi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 10 0 1 0 0 1
.100 .100 .100 . .1 .10 .100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 . 1 1 0 1 0 0 1
Compounds were compounds C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 (.). 4 10 0 1 0 0 1
the absence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 ();, 4 9 0 1 0 0 1
(n = (n ( (n (n (n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 (). 3 1 0 1 0 0 1
**P,0.01 vs. **p,0.01 * ** **P **P, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 **,... 6 3 0 1 0 0 1
doi:10.1371/journal.pone.0088736.t001 doi:10.1371/journal.pone.0088736.t001 doi:10.1371/journal.pone.0088736.t001 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 11 :./... 6 5 0 1 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 .. 2 6 0 0 1 0 0
9 9 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 7 11 no 0 10 0 0 0 0 0
a set a a a a a BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 0 ()() 4 8 1 1 0 0 1
chemically synthesized chemically c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -- 2 8 1 1 0 0 1
plumbagins were plumbagins p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 9 1 1 0 0 1
than plumbagin than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ()(.). 6 9 1 1 0 0 1
and longer and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (..,::- 7 10 1 1 0 0 1
plumbagins 2f-j) plumbagins p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -), 3 10 1 1 0 0 1
suggesting that suggesting s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 1 0 0 1
might be might m mi mig migh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -- 2 8 1 1 0 0 1
plumbagin for plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .:-() 5 9 1 1 0 0 1
strongest inhibitor strongest s st str stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 1 0 0 1
tested. In tested. t te tes test BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,:-() 6 9 1 1 0 0 1
activities of activities a ac act acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,:-() 5 10 1 1 0 0 1
did not did d di did did BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 .( 2 9 1 1 0 0 1
deoxyribonuclease I-treated deoxyribonuclease d de deo deox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 -)- 3 9 1 1 0 0 1
primer substrate primer p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 [()/- 5 9 1 1 0 0 1
go(dT) 18 go(dt) g go go( go(d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 ()(//)] 7 9 1 1 0 0 1
substrate instead substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 , 1 9 1 1 0 0 1
compounds did compounds c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 (). 3 6 1 1 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 --(-) 5 10 0 1 0 0 1
cultured human cultured c cu cul cult BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 5 0 1 0 0 1
Pols have pols P Po Pol Pols BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 3 no 0 9 0 0 0 0 1
intervention in intervention i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 -[]. 4 8 0 0 0 0 1
Therefore, the therefore, T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 ,--(-) 6 9 0 0 0 0 1
useful in useful u us use usef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 ., 2 9 0 0 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 8 0 0 0 0 1
carcinoma cells. carcinoma c ca car carc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 ..,() 5 8 0 0 0 0 1
approximately 50% approximately a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 , 1 9 0 0 0 0 1
this compound this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 ., 2 9 0 0 0 0 1
nine 5-O-acyl nine n ni nin nine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 --:-() 6 9 0 0 0 0 1
were stronger were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (). 3 9 0 0 0 0 1
C18:1-Acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 :-():-() 8 9 0 0 0 0 1
the first the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 10 0 0 0 0 1
HCT116 cells hct116 H HC HCT HCT1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 , 1 8 0 0 0 0 1
compound these compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 9 0 0 0 0 1
proliferation rate, proliferation p pr pro prol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 ,. 2 5 0 0 0 0 1
Relationship of relationship R Re Rel Rela BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -- 2 9 0 1 0 0 1
(2a-j) (2a-j) (2a-j) ( (2 (2a (2a- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (-) 3 1 0 1 0 0 1
The possible the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
four mammalian four f fo fou four BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 1 0 0 1
cell proliferation cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 1 0 0 1
the effects the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()-- 4 9 0 1 0 0 1
Figure 7. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 .:-().(-),:-() 14 9 1 0 0 0 1
(100 mM, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (,-),(,-)/.-(.). 16 10 1 0 0 0 1
Data are data D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 ().**,.*,... 12 5 1 0 0 0 1
doi:10.1371/journal.pone.0088736.g007 doi:10.1371/journal.pone.0088736.g007 doi:10.1371/journal.pone.0088736.g007 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 7 :./... 6 2 1 0 0 0 1
Table 2. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 .:-() 5 10 0 1 0 0 1
proliferation of proliferation p pr pro prol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 . 1 6 0 1 0 0 1
Human cancer human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 10 0 1 0 0 1
LD 50 ld L LD LD LD BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 () 2 7 0 1 0 0 1
A549 (lung a549 A A5 A54 A549 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 () 2 10 0 1 0 0 1
15.461.7 ** 15.461.7 1 15 15. 15.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 6 0 1 0 0 1
DU145 (prostate du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 () 2 10 0 1 0 0 1
8.860.9 ** 8.860.9 8 8. 8.8 8.86 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 4 0 1 0 0 1
HCT116 (colon hct116 H HC HCT HCT1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 () 2 10 0 1 0 0 1
6.560.6 ** 6.560.6 6 6. 6.5 6.56 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 5 0 1 0 0 1
HeLa (cervical hela H He HeL HeLa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 () 2 10 0 0 0 0 1
21.062.5 ** 21.062.5 2 21 21. 21.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 5 0 0 0 0 1
HepG2 (hepatocellular hepg2 H He Hep HepG BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 () 2 10 0 0 0 0 1
7.460.8 ** 7.460.8 7 7. 7.4 7.46 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 3 0 0 0 0 1
HT-29 cells ht-29 H HT HT- HT-2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 -() 3 10 0 1 0 0 1
2.960.4 ** 2.960.4 2 2. 2.9 2.96 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ..** 4 4 0 1 0 0 1
MCF-7 (breast mcf-7 M MC MCF MCF- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 -() 3 10 0 1 0 0 1
7.260.7 ** 7.260.7 7 7. 7.2 7.26 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ..** 4 5 0 1 0 0 1
PANC-1 (pancreatic panc-1 P PA PAN PANC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 -() 3 10 0 1 0 0 1
16.161.8 ** 16.161.8 1 16 16. 16.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ..** 4 4 0 1 0 0 1
PC3 (prostate pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 () 2 10 0 1 0 0 1
10.061.1 ** 10.061.1 1 10 10. 10.0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ..** 4 5 0 1 0 0 1
The nine the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 10 :- 2 8 0 1 0 0 1
(2f) for (2f) ( (2 (2f (2f) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ()., 4 10 0 1 0 0 1
absence of absence a ab abs abse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 ();,(). 7 9 0 1 0 0 1
**P,0.01 vs. **p,0.01 * ** **P **P, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 **,... 6 2 0 1 0 0 1
doi:10.1371/journal.pone.0088736.t002 doi:10.1371/journal.pone.0088736.t002 doi:10.1371/journal.pone.0088736.t002 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 10 :./... 6 4 0 1 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 -:- 3 10 1 0 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 .. 2 6 0 1 1 0 0
10 10 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 0 0 1 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 8 11 no 0 10 0 1 0 0 0
plumbagins (2a-j) plumbagins p pl plu plum BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (-)(.). 7 10 1 1 0 0 1
of 10 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 1 1 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 1 1 0 0 1
correlation with correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 1 1 0 0 1
cancer cell cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 1 1 0 0 1
tested, with tested, t te tes test BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 ,.. 3 9 1 1 0 0 1
of pol of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 ,, 2 8 1 1 0 0 1
showed a showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 (.) 3 9 1 1 0 0 1
proliferation rate. proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 .,, 3 10 1 1 0 0 1
which are which w wh whi whic BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 - 1 8 1 1 0 0 1
Figure 8. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 .-:-().- 8 8 1 1 0 0 1
(control), vitamin (control), ( (c (co (con BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 (),(),(),:-(),:-()/.() 22 10 1 1 0 0 1
volume in volume v vo vol volu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .();,().*,... 13 7 1 1 0 0 1
doi:10.1371/journal.pone.0088736.g008 doi:10.1371/journal.pone.0088736.g008 doi:10.1371/journal.pone.0088736.g008 d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 :./... 6 2 1 1 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 10 -:- 3 10 1 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 .. 2 6 0 0 1 0 0
11 11 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 8 11 no 0 10 0 0 0 0 0
respectively, were respectively, r re res resp BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,, 2 9 0 1 0 0 1
coefficient between coefficient c co coe coef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,.. 3 9 0 1 0 0 1
These results these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 0 1 0 0 1
activities of activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,; 2 9 0 1 0 0 1
particular, inhibition particular, p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 9 0 1 0 0 1
compounds 1 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 8 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 4 0 1 0 0 1
In particular, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 0 ,:-() 5 9 0 1 0 0 1
inhibition of inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 --(- 4 10 0 1 0 0 1
j) tested. j) j j) j) j) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ). 2 9 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (.).,:- 7 9 0 1 0 0 1
acyl plumbagin acyl a ac acy acyl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (). 3 9 0 1 0 0 1
Effects of effects E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 :-() 4 10 0 0 0 0 1
various pols various v va var vari BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 7 0 0 0 0 1
As described as A As As As BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 0 0 0 1
obtaining eleven obtaining o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,,,,, 5 9 0 0 0 0 1
e, g, e, e e, e, e, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,,,,,,;,,, 10 9 0 0 0 0 1
were not were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ., 2 8 0 0 0 0 1
eukaryotes are eukaryotes e eu euk euka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 [,], 4 9 0 0 0 0 1
and we and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 10 0 0 0 0 1
in their in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 . 1 9 0 0 0 0 1
effect (50% effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 (;):- 5 9 0 0 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 () 2 8 0 0 0 0 1
mammalian pols mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 . 1 8 0 0 0 0 1
the activity the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .- 2 9 0 0 0 0 1
10.6 mM, 10.6 1 10 10. 10.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,,,, 5 9 0 0 0 0 1
was observed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,.-.,.-.,.-., 14 9 0 0 0 0 1
respectively; therefore, respectively; r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ;, 2 9 0 0 0 0 1
the A the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .-- 3 9 0 0 0 0 1
the X the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 8 0 0 0 0 1
aphidicolin, a aphidicolin, a ap aph aphi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,,, 3 9 0 0 0 0 1
inhibitor, were inhibitor, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,,,,[], 7 8 0 0 0 0 1
inhibitory activity inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 :-().- 6 9 0 0 0 0 1
potent than potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 4 0 0 0 0 1
In contrast, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 1 ,:-() 5 8 0 0 0 0 1
pols such pols p po pol pols BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 1 ,, 2 9 0 0 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,,().- 7 8 0 0 0 0 1
dimensional structures dimensional d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 10 0 0 0 0 1
from those from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 9 0 0 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 9 0 0 0 0 1
a, 7 a, a a, a, a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,,(), 5 8 0 0 0 0 1
polynucleotide kinase, polynucleotide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,. 2 8 0 0 0 0 1
results suggest results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 --() 4 8 0 0 0 0 1
inhibitors of inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ;,() 4 8 0 0 0 0 1
conjugated with conjugated c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,:- 3 8 0 0 0 0 1
plumbagin (2f), plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (), 3 9 0 0 0 0 1
families of families f fa fam fami BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 2 0 0 0 0 1
Influence of influence I In Inf Infl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 :-() 4 10 0 0 0 0 1
hyperchromicity of hyperchromicity h hy hyp hype BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 no 0 5 0 0 0 0 1
Specific assays specific S Sp Spe Spec BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 :- 2 8 0 0 0 0 1
acyl plumbagin acyl a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 ()- 3 10 0 0 0 0 1
the compound the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 . 1 9 0 0 0 0 1
C18:1-acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 :-() 4 8 0 0 0 0 1
studying its studying s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 ., 2 9 0 0 0 0 1
(T m (t ( (T (T (T BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ():- 4 8 0 0 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 ()() 4 9 0 0 0 0 1
equipped with equipped e eq equ equi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 .., 3 9 0 0 0 0 1
thermal transition thermal t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 (..,) 5 9 0 0 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 , 1 9 0 0 0 0 1
typical intercalating typical t ty typ typi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 ,(, 3 9 0 0 0 0 1
15 mM), 15 1 15 15 15 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 6 ),, 3 8 0 1 0 0 1
transition was transition t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 3 0 1 0 0 1
The question the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 :- 2 8 0 1 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 () 2 9 0 1 0 0 1
pols or pols p po pol pols BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
determining if determining d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 [()] 4 9 0 1 0 0 1
protein (BSA; protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 (;) 3 8 0 1 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 :-().() 7 10 0 1 0 0 1
no influence no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 :-()( 5 9 0 1 0 0 1
not shown), not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ), 2 9 0 1 0 0 1
pol molecule. pol p po pol pol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 .:- 3 8 0 1 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 () 2 9 0 1 0 0 1
template-primer substrate. template-primer t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -. 2 3 0 1 0 0 1
Collectively, these collectively, C Co Col Coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ,:- 3 9 0 1 0 0 1
(2f) might (2f) ( (2 (2f (2f) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 (). 3 9 0 1 0 0 1
Subsequently, we subsequently, S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ,:- 3 9 0 1 0 0 1
acyl plumbagin acyl a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 () 2 8 0 1 0 0 1
proliferation. proliferation. proliferation. p pr pro prol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 2 0 1 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 :-() 4 10 0 0 0 0 1
cancer cell cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 3 0 0 0 0 1
C18:1-Acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 :-() 4 8 0 0 0 0 1
proliferation of proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 - 1 8 0 0 0 0 1
manner. As manner. m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 .,:-() 6 7 0 0 0 0 1
prevented the prevented p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 9 0 0 0 0 1
as A549, as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,,,,,-,-, 9 6 0 0 0 0 1
PANC-1, and panc-1, P PA PAN PANC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 -,,.-.. 7 8 0 0 0 0 1
results suggested results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 no 0 8 0 0 0 0 1
activity against activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ., 2 10 0 0 0 0 1
this compound this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 ,-, 3 8 0 0 0 0 1
values of values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ..,.- 5 9 0 0 0 0 1
by MTT by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 8 0 0 0 0 1
staining (data staining s st sta stai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (),:- 5 8 0 0 0 0 1
(2f) might (2f) ( (2 (2f (2f) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 (). 3 9 0 0 0 0 1
LD 50 ld L LD LD LD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 (), 3 9 0 0 0 0 1
must be must m mu mus must BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 9 0 0 0 0 1
pol a. pol p po pol pol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 .:-() 5 8 0 0 0 0 1
proliferation of proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 , 1 8 0 0 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ( 1 9 0 0 0 0 1
shown). shown). shown). s sh sho show BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 ). 2 1 0 0 0 0 1
Effect of effect E Ef Eff Effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 :-()- 5 10 0 0 0 0 1
activity activity activity a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 1 0 0 0 0 1
Because the because B Be Bec Beca BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 :- 2 9 0 0 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 ()- 3 9 0 0 0 0 1
human cancer human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (), 3 10 0 0 0 0 1
vivo anti-tumor vivo v vi viv vivo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 -., 3 9 0 0 0 0 1
C18:1-acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 :-()/ 5 8 0 0 0 0 1
bioactivity than bioactivity b bi bio bioa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 :-();,:- 8 9 0 0 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 ()(),(), 8 9 0 0 0 0 1
C18:1-acyl juglone c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 :-(). 5 3 0 0 0 0 1
HT-29 cells ht-29 H HT HT- HT-2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 -. 2 9 0 0 0 0 1
12 days 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 9 , 1 9 0 0 0 0 1
groups (one groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 () 2 8 0 0 0 0 1
mouse group mouse m mo mou mous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 - 1 8 0 0 0 0 1
102 mm 102 1 10 102 102 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 9 . 1 8 0 0 0 0 1
compound dissolved compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (/)- 4 9 0 0 0 0 1
days. As days. d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .., 3 8 0 0 0 0 1
growth as growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (), 3 8 0 0 0 0 1
decreased rates decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 9 0 0 0 0 1
with vitamin with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (),(),:-(), 11 9 0 0 0 0 1
C18:1-acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 :-().,.,.,., 12 8 0 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 .. 2 6 0 0 1 0 0
12 12 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 10 11 no 0 10 0 0 0 0 0
respectively. C18:1-acyl respectively. r re res resp BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .:-()- 6 9 0 1 0 0 1
stronger anti-tumor stronger s st str stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -, 2 8 0 1 0 0 1
suggesting that suggesting s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :-(), 5 9 0 1 0 0 1
but C18:1-acyl but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :-(). 5 9 0 1 0 0 1
found between found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --() 4 8 0 1 0 0 1
mammalian pols, mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,(.). 5 8 0 1 0 0 1
C18:1-Acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 :-() 4 9 0 1 0 0 1
tumor in tumor t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 , 1 9 0 1 0 0 1
pols and pols p po pol pols BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 0 no 0 9 0 1 0 0 1
lead to lead l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 9 0 1 0 0 1
None of none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
weight throughout weight w we wei weig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 (.). 4 9 0 1 0 0 1
noted that noted n no not note BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,,, 4 10 0 1 0 0 1
spleen, heart, spleen, s sp spl sple BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,,,,, 6 9 0 1 0 0 1
and testis and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
histological appearance histological h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ();,:- 6 9 0 1 0 0 1
plumbagin (2f) plumbagin p pl plu plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ()- 3 10 0 1 0 0 1
treatment. treatment. treatment. t tr tre trea BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 1 0 1 0 0 1
Conclusions Conclusions conclusions C Co Con Conc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 10 0 0 0 0 1
We previously we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 (--,-- 6 8 0 0 0 0 1
quinone), juglone quinone), q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 ),(--,-) 8 8 0 0 0 0 1
with fatty with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 . 1 10 0 0 0 0 1
study, 5-O-acyl study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,--(),(-- 9 9 0 0 0 0 1
2-methyl-1,4-naphthoquinone) conjugated 2-methyl-1,4-naphthoquinone) 2 2- 2-m 2-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 --,-), 6 9 0 0 0 0 1
produced to produced p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 . 1 9 0 0 0 0 1
the synthesized the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 --(-),- 7 9 0 0 0 0 1
compounds. These compounds. c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 .- 2 8 0 0 0 0 1
itors of itors i it ito itor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 ,,, 3 9 0 0 0 0 1
families B, families f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,,,,,(). 8 9 0 0 0 0 1
synthesized compounds, synthesized s sy syn synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,:-() 5 8 0 0 0 0 1
strongest suppression strongest s st str stro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 . 1 8 0 1 0 0 1
human cancer human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 9 0 1 0 0 1
the inhibition the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 9 0 1 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 .:-() 5 9 0 1 0 0 1
inhibited the inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 10 0 1 0 0 1
suppressed human suppressed s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 9 0 1 0 0 1
anti-tumor activity anti-tumor a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 2 -.- 3 9 0 1 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 :-() 4 8 0 1 0 0 1
C18:1-acyl juglone c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 :-(),:-() 9 8 0 1 0 0 1
more stable more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 :-(). 5 9 0 1 0 0 1
These results these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 --(), 5 8 0 1 0 0 1
C18:1-acyl plumbagin c18:1-acyl C C1 C18 C18: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 :-(),-- 7 8 0 1 0 0 1
therapy agents therapy t th the ther BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 . 1 7 0 1 0 0 1
Acknowledgments Acknowledgments acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 no 0 10 0 0 0 0 1
We are we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 :.. 3 10 0 0 0 0 1
of Tokyo of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 (,);, 5 10 0 0 0 0 1
and e and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 ..(,); 6 9 0 0 0 0 1
human pol human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 .. 2 9 0 0 0 0 1
(Nagoya, Japan); (nagoya, ( (N (Na (Nag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 (,);.. 6 8 0 0 0 0 1
Gakushuin University gakushuin G Ga Gak Gaku BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 (,).. 5 8 0 0 0 0 1
University (Nagoya, university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 (,);.. 6 8 0 0 0 0 1
University (Kyoto, university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 (,);.. 6 9 0 0 0 0 1
Tokyo University tokyo T To Tok Toky BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 (,). 4 9 0 0 0 0 1
mass spectrometers mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 /() 3 8 0 0 0 0 1
Institute for institute I In Ins Inst BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 3 ,. 2 6 0 0 0 0 1
Author Contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 10 0 0 0 0 1
Conceived and conceived C Co Con Conc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 :. 2 9 0 0 0 0 1
experiments: MK experiments: e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 :.:. 4 8 0 0 0 0 1
Contributed reagents/materials/analysis contributed C Co Con Cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 //:. 4 10 0 0 0 0 1
the paper: the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 :. 2 2 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 10 0 0 0 0 1
1. Berdis 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .(). 4 9 0 0 0 0 1
(Moscow) 47: (moscow) ( (M (Mo (Mos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ():-. 5 3 0 0 0 0 1
2. Sakaguchi 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,() 5 9 0 0 0 0 1
polymerases. Seikagaku polymerases. p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .:-. 4 4 0 0 0 0 1
3. Surh 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .(). 4 9 0 0 0 0 1
Rev Cancer rev R Re Rev Rev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
4. Liu 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .(): 4 9 0 0 0 0 1
mechanism of mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .:-. 4 5 0 0 0 0 1
5. Kornberg 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,().... 8 9 0 0 0 0 1
York, University york, Y Yo Yor York BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.-. 4 5 0 0 0 0 1
6. Bebenek 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,(). 5 9 0 0 0 0 1
Chem 69: chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
7. Hubscher 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,(). 6 9 0 0 0 0 1
Biochem 71: biochem B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
8. Loeb 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.(). 6 9 0 0 0 0 1
Rev Genet rev R Re Rev Rev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
9. Lange 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,(). 6 9 0 0 0 0 1
Rev Cancer rev R Re Rev Rev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
10. Mizushina 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .(). 4 10 0 0 0 0 1
Biosci Biotechnol biosci B Bi Bio Bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 :-. 3 5 0 0 0 0 1
11. Mizushina 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .() 3 9 0 0 0 0 1
components and components c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .:-. 4 7 0 0 0 0 1
12. Mizushina 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,() 5 9 0 0 0 0 1
DNA polymerases dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -,,, 4 9 0 0 0 0 1
compounds. Curr compounds. c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .:-. 4 5 0 0 0 0 1
13. Sasaki 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,.() 9 9 0 0 0 0 1
polymerase c polymerase p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 0 0 0 0 1
cytotoxicity in cytotoxicity c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .:-. 4 7 0 0 0 0 1
14. Monks 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,() 7 8 0 0 0 0 1
chemistry and chemistry c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .:-. 4 7 0 0 0 0 1
15. O'Brien 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .'(). 5 9 0 0 0 0 1
Interact 80: interact I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :-. 3 2 0 0 0 0 1
16. Bolton 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,() 7 9 0 0 0 0 1
quinones in quinones q qu qui quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 5 .:-. 4 6 0 0 0 0 1
17. Cho 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,.() 9 8 0 0 0 0 1
Determination of determination D De Det Dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 8 0 0 0 0 1
and Atmospheric and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..:- 4 6 0 0 0 0 1
18. Mossa 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,-,() 6 9 0 0 0 0 1
from Juniperus from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 , 1 9 0 0 0 0 1
synergistic activity synergistic s sy syn syne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 8 .:-. 4 9 0 0 0 0 1
19. Srinivas 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,() 7 9 0 0 0 0 1
induces reactive induces i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 , 1 9 0 0 0 0 1
cancer cells. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .:-. 4 4 0 0 0 0 1
20. Tilak 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,() 5 8 0 0 0 0 1
Plumbagozeylanica, an plumbagozeylanica, P Pl Plu Plum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 ,,. 3 10 0 0 0 0 1
Redox Rep redox R Re Red Redo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 :-. 3 2 0 0 0 0 1
21. Ding 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.()- 10 9 0 0 0 0 1
activity by activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ,-. 3 8 0 0 0 0 1
Pharmacol 57: pharmacol P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 :-. 3 2 0 0 0 0 1
22. Lee 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.() 9 9 0 0 0 0 1
agent plumbagin agent a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 - 1 8 0 0 0 0 1
cells by cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 -.:. 4 8 0 0 0 0 1
23. Maruo 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.() 9 8 0 0 0 0 1
Inhibitory effect inhibitory I In Inh Inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 -- 2 8 0 0 0 0 1
activity, cancer activity, a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ,.: 3 9 0 0 0 0 1
5803-5812. 5803-5812. 5803-5812. 5 58 580 5803 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 -. 2 1 0 0 0 0 1
24. Tamai 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.() 9 9 0 0 0 0 1
study of study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 -- 2 8 0 0 0 0 1
from calf from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .:-. 4 6 0 0 0 0 1
25. Date 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.() 9 8 0 0 0 0 1
Expression of expression E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 .: 2 9 0 0 0 0 1
2983-2990. 2983-2990. 2983-2990. 2 29 298 2983 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 8 -. 2 1 0 0 0 0 1
26. Umeda 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,,.()- 10 9 0 0 0 0 1
loop structure loop l lo loo loop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 --- 3 8 0 0 0 0 1
phenylpyridinium ion phenylpyridinium p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 8 (),-. 5 9 0 0 0 0 1
267: 200-206. 267: 2 26 267 267: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 :-. 3 1 0 0 0 0 1
27. Oshige 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,() 7 8 0 0 0 0 1
protein-affinity isolation protein-affinity p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 -. 2 10 0 0 0 0 1
Expr Purif expr E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 :-. 3 2 0 0 0 0 1
28. Kusumoto 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,,() 7 9 0 0 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 : 1 8 0 0 0 0 1
polymerase switching polymerase p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 8 .:-. 4 8 0 0 0 0 1
29. Biertu 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,,,-,,.() 10 9 0 0 0 0 1
Structure and structure S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 .:- 3 8 0 0 0 0 1
1048. 1048. 1048. 1 10 104 1048 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 8 . 1 0 0 0 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 .. 2 6 0 0 1 0 0
13 13 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 11 11 no 0 10 0 0 0 0 0
30. Ohashi 30. 3 30 30. 30. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,.() 9 10 0 1 0 0 1
of hREV1 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -.:- 4 8 0 1 0 0 1
531. 531. 531. 5 53 531 531. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 0 0 1 0 0 1
31. Shimazaki 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,.()- 10 9 0 1 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 9 0 1 0 0 1
recombinant enzyme. recombinant r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .:-. 4 5 0 1 0 0 1
32. Sakaguchi 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,()- 6 9 0 1 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .:-. 4 9 0 1 0 0 1
33. Uchiyama 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,() 7 9 0 1 0 0 1
DNA polymerase dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 , 1 9 0 1 0 0 1
and meiotic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .:-. 4 6 0 1 0 0 1
34. Mizushina 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,.() 9 9 0 1 0 0 1
acids selectively acids a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 9 0 1 0 0 1
Biophys Acta biophys B Bi Bio Biop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :-. 3 3 0 1 0 0 1
35. Mizushina 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,() 6 9 0 1 0 0 1
action of action a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .:- 3 9 0 1 0 0 1
521. 521. 521. 5 52 521 521. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 0 0 1 0 0 1
36. Ogawa 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,(), 8 9 0 1 0 0 1
putative tumor putative p pu put puta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,. 2 9 0 1 0 0 1
Res 89: res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :-. 3 2 0 1 0 0 1
37. Tamiya-Koizumi 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .-,,,,,. 8 9 0 1 0 0 1
(1997) Inhibition (1997) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 () 2 9 0 1 0 0 1
with their with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 9 0 1 0 0 1
Biol Int biol B Bi Bio Biol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :-. 3 2 0 1 0 0 1
38. Nakayama 38. 3 38 38. 38. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,()---- 8 9 0 1 0 0 1
nine 59-triphosphate nine n ni nin nine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -- 2 8 0 1 0 0 1
salmon (Oncorhynchus salmon s sa sal salm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 6 ().():-. 8 7 0 1 0 0 1
39. Mizushina 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,.() 9 9 0 1 0 0 1
Inhibitory action inhibitory I In Inh Inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 . 1 8 0 1 0 0 1
Biochimie 89: biochimie B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 :-. 3 2 0 1 0 0 1
40. Soltis 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,() 4 9 0 1 0 0 1
forms of forms f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .:-. 4 7 0 1 0 0 1
41. Lu 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,()- 5 9 0 1 0 0 1
basidiomycete Coprinus basidiomycete b ba bas basi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 :. 2 10 0 1 0 0 1
266: 21060-21066. 266: 2 26 266 266: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 :-. 3 2 0 1 0 0 1
42. Mizushina 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,.() 9 8 0 1 0 0 1
Selective inhibition selective S Se Sel Sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 1 0 0 1
DNA topoisomerases dna D DN DNA DNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .:-. 4 7 0 1 0 0 1
43. Mosmann 43. 4 43 43. 43. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .(): 4 9 0 1 0 0 1
application to application a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .:- 3 9 0 1 0 0 1
63. 63. 63. 6 63 63. 63. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 . 1 0 0 1 0 0 1
44. Mathew 44. 4 44 44. 44. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,.() 9 8 0 1 0 0 1
Inhibition of inhibition I In Inh Inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 9 0 1 0 0 1
Des 76: des D De Des Des BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 :-. 3 1 0 1 0 0 1
45. Mizushina 45. 4 45 45. 45. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,.() 9 9 0 1 0 0 1
Dehydroaltenusin, a dehydroaltenusin, D De Deh Dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,. 2 8 0 1 0 0 1
275: 33957-33961. 275: 2 27 275 275: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 :-. 3 2 0 1 0 0 1
Anti-Tumor Activity anti-tumor A An Ant Anti BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 -:- 3 10 0 1 0 0 0
PLOS ONE plos P PL PLO PLOS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 .. 2 6 0 0 1 0 0
14 14 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 0 0 0 0 0 0
February 2014 february F Fe Feb Febr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 11 11 no 0 10 0 0 0 0 0

